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Highly resistant tumor cells are hard to treat at low doses of plasma.
Therefore, researchers have gained more attention to development
of enhancers for plasma therapy. Some enhancers could improve
the efﬁcacy of plasma towards selectivity of cancer cells damage. In
this dataset, we report the application of low doses of PEG-coated
gold nanoparticles with addition of plasma treatment. This data
consists of the effect of PEG-coated GNP and cold plasma on two
solid tumor cell lines T98G glioblastoma and A549 lung adeno-
carcinoma. Cell proliferation, frequency of cancer stem cell popu-
lation studies by this co-treatment was reported. Finally, we inclu-
ded in this dataset the effect of co-treatment in vivo, using tumor
xenograft nude mice models. The data supplied in this article sup-
ports the accompanying publication “Low doses of PEG-coated gold
nanoparticles sensitize solid tumors to cold plasma by blocking the
PI3K/AKT-driven signaling axis to suppress cellular transformation
by inhibiting growth and EMT” (N. K. Kaushik, N. Kaushik, K. C. Yoo,
N Uddin, J. S. Kim, S. J. Lee et al., 2016) [1].
& 2016 The Authors. Published by Elsevier Inc. This is an open access
article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
/j.biomaterials.2016.02.014
N.K. Kaushik), sj0420@hanyang.ac.kr (S.J. Lee), ehchoi@kw.ac.kr (E.H. Choi).
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Dubject area Material Science, Biology, Physics
ore speciﬁc sub-
ject areaPlasma medicine, Nano-medicine, Nanotechnologyype of data Graph, ﬁgure
ow data was
acquiredNikon Ti-U Microscope, Biotek Synergy HT Multiwell Plate Reader, BD FACS-
Verse Flow Cytometer, ELDA Softwareata format Analyzed
xperimental
factorsPEG coated gold nanoparticles and nonthermal plasma
T98G glioma and A549 adenocarcinoma cancer cell line for in vitro experiments
and U87 Glioma cells for in vivo animal studyxperimental
featuresViability, Cell morphology, Cell death by ﬂow-cytometer, Limiting dilution assay,
Tumor volume,ata source
locationKwangwoon University (Plasma Bioscience Research Center) and Hanyang
University (Department of Life Science), Seoul, Republic of Koreaata accessibility Data are available within this articleValue of the data
 This data will be helpful for the scientiﬁc community that evaluates various nanomaterials as a
cancer targeted therapy for improving existing cancer therapeutic approaches.
 This data allows the scientiﬁc community to elucidate the mechanistic basis of gold nanoparticles
and plasma-induced cell destruction.
 This data conﬁrmed that cancer stem cell populations could be suppressed through GNP and
plasma co-treatment.
 This data elucidates the theses co-treatments have potential to inhibit tumor cell growth
in vivo also.1. Data
We applied the combination approach to inhibit solid tumor growth using gold nanoparticles and
air micro dielectric barrier discharge plasma. In this data, T98G and A549 cells decreased cell pro-
liferation in dose and incubation time-dependent manner (Figs. 1 and 2). Next, we utilized this effect
on CSC maintenance, there was a decrease observed in frequency of stem cell population (Fig. 3). This
dataset also depicts the analysis of tumor size in vivo (Fig. 4). Tumor growth was signiﬁcantly
inhibited in treated tumors as compared to untreated tumors.2. Experimental design, materials and methods
2.1. Cell proliferation assay
Cell viability was determined using MTT assays in GNP plus plasma co-treated solid cancer cells.
The colorimetric MTT test evaluates cell metabolic activity based on the capability of mitochondrial
succinate reductase to convert a yellow-colored dye (MTT) to purple formazan in living cells. The
color density of the purple-colored formazan crystals is directly proportional to the metabolic activity
of the cells. MTT assays were performed according to previously reported methods [2,3].
Fig. 1. Response of gold nanoparticles and cold plasma on solid tumor cells. T98G glioblastoma and A549 lung adenocarcinoma
cells which were treated with (A & B) Plasma alone in T98G and A549 cell respectively. (C & D) Gold nanoparticles (GNP) alone
using different concentrations in T98G and A549 cell respectively. (E) Phase-contrast microscopic images of both cancer cell
lines co-treated with GNP (100 nM) and cold plasma (150 s). Cell metabolic viability was analyzed by MTT assay following 24,
48 and 72 h using plate reader at 540 nm.
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Fig. 2. Relative cell death of 100 nM GNP and 150 s plasma (Pls) treated T98G cells as measured by ﬂow cytometry using
propidium iodide (PI) staining at similar doses following 24 h.
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For quantiﬁcation of cell death, cells were stained with propidium iodide (PI). The cells were
harvested using trypsinization, washed in phosphate-buffered saline and then incubated in PI (50
ng/mL) for 5 min at room temperature. Then immediately analyzed using BD FACSVerse using the
FACS suite software.
2.3. Limiting dilution assay
Treated with vehicle and combination (GNPþplasma) glioma-like stem cells were enzymatically
dissociated into single-cell suspensions, plated into 96-well plates with various seeding densities (0, 1,
3, 5, 10, 15, 20 cells per well). After cell seeding, the plate incubated at 37 °C for 10–15 days. On day 15,
each well was observed under a microscope for the determination of individual tumor cell sphere
formation. Positive wells with sphere formation were counted and log fraction of wells without
spheres was plotted, and data was calculated using the Extreme Limiting Dilution Analysis (http://
bioinf.wehi.edu.au/software/elda/index.html).
2.4. Tumor volume measurement
U87 Glioma cells (106 cells) in 200 μl PBS were injected subcutaneously into right hind ﬂan of
BALB/c female nude mice. Incomplete DMEMmedia is treated with 10 min dielectric barrier discharge
(DBD) plasma exposure to prepare plasma-activated media (PAM) [1]. Mice were treated via sub-
cutaneous injection into tumors with 0.5 mg/kg body weight of GNP in PBS and 200 μl PAM in same
group. PAM is injected four times at every next days after single dose of GNP treatment. Treated group
describes treatment with both GNP and PAM. Tumor size was measured with a caliper (calculated
volume¼shortest diameter2 longest diameter/2) with 3 day intervals. This study was reviewed and
Fig. 4. Time-dependent changes in the tumor volume in xenografted models are shown; each point on the line graph
represents the mean tumor volume (mm3) for each group on a particular day after implantation.
Fig. 3. Limiting dilution assay performed on glioma cells after co-treatment with gold nanoparticles and plasma. GNP denotes
gold nanoparticles and Pls denotes plasma.
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